SE7704545L - Forfarande for framstellning av nya adeninderivat - Google Patents

Forfarande for framstellning av nya adeninderivat

Info

Publication number
SE7704545L
SE7704545L SE7704545A SE7704545A SE7704545L SE 7704545 L SE7704545 L SE 7704545L SE 7704545 A SE7704545 A SE 7704545A SE 7704545 A SE7704545 A SE 7704545A SE 7704545 L SE7704545 L SE 7704545L
Authority
SE
Sweden
Prior art keywords
procedure
preparing new
adenine derivatives
new adenine
derivatives
Prior art date
Application number
SE7704545A
Other languages
English (en)
Swedish (sv)
Inventor
C Credner
G Brenner
M Tauscher
L Jozic
Original Assignee
Wuelfing J A Fa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB1672076A external-priority patent/GB1530166A/en
Application filed by Wuelfing J A Fa filed Critical Wuelfing J A Fa
Publication of SE7704545L publication Critical patent/SE7704545L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7704545A 1976-04-24 1977-04-20 Forfarande for framstellning av nya adeninderivat SE7704545L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1672176 1976-04-24
GB1672076A GB1530166A (en) 1976-04-24 1976-04-24 Adenine derivatives

Publications (1)

Publication Number Publication Date
SE7704545L true SE7704545L (sv) 1977-10-25

Family

ID=26252198

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7704545A SE7704545L (sv) 1976-04-24 1977-04-20 Forfarande for framstellning av nya adeninderivat

Country Status (12)

Country Link
US (1) US4123534A (xx)
JP (1) JPS52151194A (xx)
AU (1) AU2450777A (xx)
DE (1) DE2716837A1 (xx)
DK (1) DK178677A (xx)
ES (1) ES458123A1 (xx)
FI (1) FI771206A (xx)
FR (1) FR2348926A1 (xx)
IE (1) IE44739B1 (xx)
NL (1) NL7704290A (xx)
SE (1) SE7704545L (xx)
YU (1) YU96177A (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU76148A1 (xx) * 1976-11-08 1978-07-10
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
DE3062034D1 (en) * 1979-07-25 1983-03-24 Beecham Wuelfing Gmbh & Co Kg Adenine derivatives possessing pharmacological activity
NL8700245A (nl) * 1986-02-14 1987-09-01 Sandoz Ag Purinederivaten, werkwijzen voor hun bereiding en geneesmiddelen die deze derivaten bevatten.
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412093A (en) * 1965-12-21 1968-11-19 Delmar Chem New adenine derivatives and method for their preparation

Also Published As

Publication number Publication date
JPS52151194A (en) 1977-12-15
FR2348926A1 (fr) 1977-11-18
DE2716837A1 (de) 1977-11-10
AU2450777A (en) 1978-10-26
NL7704290A (nl) 1977-10-26
IE44739B1 (en) 1982-03-10
US4123534A (en) 1978-10-31
YU96177A (en) 1982-08-31
FI771206A (xx) 1977-10-25
DK178677A (da) 1977-10-25
ES458123A1 (es) 1978-10-16
IE44739L (en) 1977-10-24

Similar Documents

Publication Publication Date Title
SE7610422L (sv) Forfarande for framstellning av pyrimidinderivat
NO782768L (no) Fremgangsmaate for fremstilling av alkenderivater
SE442400B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner
SE430601B (sv) Analogiforfarande for framstellning av nya dipeptidderivat
SE7806710L (sv) Nya karbostyrilderivat
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
SE7704545L (sv) Forfarande for framstellning av nya adeninderivat
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
SE7701459L (sv) Forfarande for framstellning av nya derivat av 1,2-ditiol
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7811457L (sv) Nya kinolylguanidinderivat
SE7800739L (sv) Nya aminoalkoxifenylderivat
SE424553B (sv) Forfarande for framstellning av nya indazol-derivat
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
SE440903B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-aminopropaner
SE7703634L (sv) Forfarande for framstellning av nya amidinopenicillanoyloxialkylamoxicillinater